Sort
51,570 grants matching “autoimmune disease”
A multivalent prophylactic and therapeutic vaccine against EBV infection and EBV-associated malignancies
$858,605Javier Gordon Ogembo · Beckman Research Institute/City Of Hope · R56 · FY2020 · AI
Decoding T cell clonotypes, biology and predictive biomarkers associated with immune checkpoint Myocarditis
$858,186Alexandra-Chloe Villani · Massachusetts General Hospital · R01 · FY2025 · AI
Assessment, Therapy and Prevention Of Autoimmune Disease
$858,012Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules
$857,968John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Novel PARS inhibitor for therapy of colitis
$857,140Inotek Pharmaceuticals Corporation · R44 · FY2002 · DK
Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations
$857,021Lisa Forbes · Baylor College Of Medicine · UH3 · FY2025 · TR
Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis
$856,782Chad Allen Koplinski · Xlock Biosciences, Llc · R44 · FY2020 · AR
Quantitative measurement of T1D risk through molecular signature analysis
$856,742Martin John Hessner · Medical College Of Wisconsin · DP3 · FY2013 · DK
Disease and Race Specific Single-cell Epigenetic Mechanisms in Human SLE
$856,476Patrick M Gaffney · Oklahoma Medical Research Foundation · R01 · FY2022 · AI
REPTOR: accelerating antibody discovery and improving hits with machine learning
$856,396Natalie Castellana · Abterra Biosciences, Inc. · R44 · FY2024 · GM
STudy of Acute HIV for investiGating Eradication Strategies (STAGES): The role of IL-10 and IFN signaling
$856,202Sulggi Angela Lee · University Of California, San Francisco · R01 · FY2025 · AI
Transformative Computational Infrastructures for Cell-Based Biomarker Diagnostics
$855,992Richard H Scheuermann · J. Craig Venter Institute, Inc. · U01 · FY2016 · TR
Genome-Wide Association Study in African-Americans with Rheumatoid Arthritis
$855,820S Louis Bridges · University Of Alabama At Birmingham · R01 · FY2009 · AR
A proprietary single-cell analytics platform for accelerating biologics manufacturing
$855,264Ayca Yalcin Ozkumur · Onecyte Biotechnologies, Inc. · R44 · FY2021 · TR
A proprietary single-cell analytics platform for accelerating biologics manufacturing
$855,264Ayca Yalcin Ozkumur · Onecyte Biotechnologies, Inc. · R44 · FY2022 · TR
Project 3: Defining the antibody landscape after SARS-CoV-2 infection
$855,062Sabra L Klein · Johns Hopkins University · U54 · FY2020 · CA
Gene Expression Signatures to Predict Treatment Response in Systemic Sclerosis
$854,879Michael W Fanger · Celdara Medical, Llc · R44 · FY2015 · AR
Depletion, Repopulation and Tolerance in Non-Sensitied Recipients
$854,803Allan D. Kirk · Duke University · U19 · FY2021 · AI
ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN
$854,715Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2009 · DK
ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN
$854,715Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2008 · DK
CELLULAR AND MOLECULAR STUDIES OF AUTOIMMUNE DISEASES
$854,654Mount Sinai School Of Medicine Of Nyu · P01 · FY2000 · AI
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis and other Immune related Diseases
$854,395Rosh Chandraratna · Io Therapeutics, Inc. · R44 · FY2016 · AI
Regulatory T cells and the tumor microenvironment
$854,385Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R35 · FY2024 · CA
Plasmacytoid dendritic cells and IgA autoantibodies in SLE
$854,187Jessica A Hamerman · Benaroya Research Inst At Virginia Mason · R01 · FY2024 · AI
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2
$853,827Steven B Abramson · New York University School Of Medicine · R01 · FY2023 · HL